CMPX · Compass Therapeutics, Inc.
$2.38
+0.02 (+0.64%)
At close · Aug 21
Market Cap
$425.01M
Shares
180.09M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$2.36
Open$2.42
Day$2.31–2.46
52W close$1.67–6.69
Avg vol 30d3.0M
Short int39.9M · 22.1% float · 17.6d
Short vol51%
Last earningsMay 20, 2026
DataApr 2021–Aug 2026
Filing10-Q · Aug 6
Up next
Next earnings call
Nov 26, 2026
Est · unconfirmed
· in 14 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 6, 2026
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Weak
Sentiment
Neutral
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 14.9 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−42%
below
Price vs 50-day avg
+11%
above
RSI (14)
59
neutral
MACD trend
Positive
52-week position
14%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+11%
trailing
6-month return
−58%
trailing
YTD return
−56%
this year
Relative strength
−69%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $2 › 200d $4 — 200d above 50d
Institutional flow
Accumulating
+4% holders QoQ · +63 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
22.14% of float · ▲ +1.5% MoM · 17.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
213 holders — near 3-yr high, broad support
Squeeze score
83
high risk · 0–100
Fundamentals
Revenue growth
−100%
Y/Y
Free cash flow
$-49.2M
Balance sheet
$30.6M
net cash
Quant / Vol
risk profile
Volatility
90%
annualized · 1-yr
Max drawdown
−75%
past year
ATR
5.9%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−42%
Bearish
Price vs 50-day avg
+11%
Bullish
RSI (14)
59
Neutral
MACD trend
Positive
Bullish
52-week position
14%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $2 › 200d $4 — 200d above 50d
Institutional flow
Accumulating
+4% holders QoQ · +63 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
22.14% of float · ▲ +1.5% MoM · 17.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
213 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $2
Now $2 · 14%
Range high $7
vs 200-day avg -42%
vs 50-day avg +11%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| cash and marketable securities | $195M | Q1 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CMPX
this stock
Compass Therapeutics, Inc.
|
$425.01M | -56.1% | -100.0% | — | 22.1% |
|
ONC
BeOne Medicines Ltd.
|
$557.05B | +21.5% | +22179.2% | 856.5 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$136.93B | +19.2% | +46.2% | 31.5 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$86.39B | +7.1% | +20.8% | 20.8 | 3.3% |
|
MRNA
Moderna, Inc.
|
$69.62B | +352.1% | +4.3% | — | 12.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CMPX | +4.4% | +11.3% | -58.2% | +23.6% | -56.1% |
| SPY | -2.0% | +3.3% | +11.2% | +2.1% | +11.8% |
| vs SPY | +6.4% | +8.0% | -69.4% | +21.5% | -67.9% |